- Report
- June 2025
- 250 Pages
India
From €2452EUR$2,789USD£2,136GBP
- Report
- June 2025
- 250 Pages
Japan
From €2452EUR$2,789USD£2,136GBP
- Report
- April 2023
- 147 Pages
Global
From €4350EUR$4,949USD£3,790GBP
- Report
- October 2025
- 24 Pages
Singapore
From €995EUR$1,213USD£897GBP
- Report
- October 2025
- 120 Pages
France
From €2675EUR$3,260USD£2,412GBP
- Report
- October 2025
- 96 Pages
Portugal
From €2675EUR$3,260USD£2,412GBP
- Report
- October 2025
- 103 Pages
Netherlands
From €2675EUR$3,260USD£2,412GBP
- Report
- September 2025
- 112 Pages
Norway
From €2675EUR$3,260USD£2,412GBP
- Report
- September 2025
- 101 Pages
Argentina
From €2675EUR$3,260USD£2,412GBP
- Report
- August 2024
- 223 Pages
China
From €3516EUR$4,000USD£3,063GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,265USD£3,156GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$4,265USD£3,156GBP
- Report
- May 2022
- 99 Pages
Global
From €3500EUR$4,265USD£3,156GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,213USD£897GBP
- Report
- October 2025
- 23 Pages
Portugal
From €995EUR$1,213USD£897GBP
- Report
- October 2025
- 79 Pages
Latvia
From €2675EUR$3,260USD£2,412GBP
- Report
- October 2025
- 20 Pages
Latvia
From €995EUR$1,213USD£897GBP
- Report
- October 2025
- 21 Pages
Latvia
From €995EUR$1,213USD£897GBP
- Report
- October 2025
- 23 Pages
Netherlands
From €995EUR$1,213USD£897GBP
- Report
- September 2025
- 73 Pages
Costa Rica
From €2675EUR$3,260USD£2,412GBP

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more